Study of Hypercortisolism in Patients with Difficult to Control Type 2 Diabetes Despite Receiving Standard-of-Care Therapies: Prevalence and Treatment with Korlym® (Mifepristone) (CATALYST)

14771CATALYST-1073-310Open (affiliates only)Study of Hypercortisolism in Patients with Difficult to Control Type 2 Diabetes Despite Receiving Standard-of-Care Therapies: Prevalence and Treatment with Korlym® (Mifepristone) (CATALYST)Protocol C-1073-310NCT05772169IndustrialAdultTreatmentIVNationalOtherPark, JeanMedStar Community Clinical Research Center : Maria Hurtado; MedStar Community Clinical Research Center - Hyattsville : Maria Hurtado; MedStar Medical Group - Hyattsville Clinic : Maria HurtadoMHRI Community Research7043Maria HurtadoMaria HurtadoMaria.E.Hurtado@medstar.net2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>